Analyst: There may be a RRR cut of 50 basis points to 100 basis points next year. Tan Yiming, chief fixed income analyst of Minsheng Securities, said that there may be a RRR cut of 50 basis points to 100 basis points next year, considering the supply pressure of government bonds, the restoration of credit supply and the provision of long-term stable low-cost funds for financial institutions.Xia Yiping, CEO of Extreme Vietnam: The company is experiencing difficulties at present, and the company needs to adjust immediately. On December 11th, it was learned from the inside of Extreme Vietnam Automobile that Xia Yiping, CEO of Extreme Vietnam, communicated with all employees through video conference, frankly indicating that the company is experiencing difficulties at present, and the company needs to adjust immediately and enter the 2.0 stage of entrepreneurship. The management will go all out to tide over the difficulties with all employees. Xia Yiping said that in the new entrepreneurial period, the following four things must be done well: 1. Adhere to the long-term investment in core technologies to maintain the leading edge; 2. Strengthen sales and service capacity building to cope with fierce market competition; 3. Merge departments and posts with duplicate functions and change inefficient internal workflow; 4. Reduce projects that cannot improve financial performance in the short term. (Blue Whale Finance)Bank of America: Resume the coverage of Lilly and give it a "buy" rating with a target price of $997.
Senior US official: Russia has provided important assistance to Iran in fighter planes, missile defense and space technology.Kazakhstan said that Russia's Druzhba oil pipeline was not damaged by Ukraine's overnight strike.China Automotive Power Battery Industry Innovation Alliance: In November, the sales volume of power batteries in China increased by 29.7% year-on-year. According to the monthly information of power batteries in November 2024 released by China Automotive Power Battery Industry Innovation Alliance, the sales volume of power batteries and other batteries in China was 118.3GWh in November, up by 7.2% month-on-month and 40.1% year-on-year. Among them, the sales volume of power batteries was 87.8GWh, accounting for 74.2% of the total sales volume, up 10.9% from the previous month and 29.7% from the same period last year. The sales volume of other batteries was 30.5GWh, accounting for 25.8% of the total sales volume, down 2.2% from the previous month and up 82.3% year-on-year. From January to November, the cumulative sales volume of power and other batteries in China was 914.3GWh, a cumulative year-on-year increase of 42.8%. Among them, the cumulative sales of power batteries was 692.3GWh, accounting for 75.7% of the total sales, with a cumulative year-on-year increase of 27.1%; The cumulative sales volume of other batteries was 222.0GWh, accounting for 24.3% of the total sales volume, with a cumulative year-on-year increase of 132.5%.
Xia Yiping, CEO of Extreme Vietnam: The company is experiencing difficulties at present, and the company needs to adjust immediately. On December 11th, it was learned from the inside of Extreme Vietnam Automobile that Xia Yiping, CEO of Extreme Vietnam, communicated with all employees through video conference, frankly indicating that the company is experiencing difficulties at present, and the company needs to adjust immediately and enter the 2.0 stage of entrepreneurship. The management will go all out to tide over the difficulties with all employees. Xia Yiping said that in the new entrepreneurial period, the following four things must be done well: 1. Adhere to the long-term investment in core technologies to maintain the leading edge; 2. Strengthen sales and service capacity building to cope with fierce market competition; 3. Merge departments and posts with duplicate functions and change inefficient internal workflow; 4. Reduce projects that cannot improve financial performance in the short term. (Blue Whale Finance)Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Putin had a phone conversation with Hungarian President Orban on the situation in Ukraine. According to the Tass news agency, Russian President Vladimir Putin and Hungarian Prime Minister Orban discussed the further development of energy projects.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide
12-13